Back to Search Results- Not Yet Recruiting
- Observational
- Power Life Sciences Inc.
- 18 Years -
Study Purpose
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This research will admit a wide range of data on the clinical study experience of metastatic prostate cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with metastatic prostate cancer.
Intervention
N/A
Eligibility Requirements
Patient is at least 18 years of age
Diagnosis of metastatic prostate cancer
Ability to understand and the willingness to sign a written informed consent document
Enrolled in another research study
Patients with psychiatric illness/social situations that would limit compliance with study requirements
Inability to provide written informed consent
Recruiting status
Not Yet Recruiting
Estimated enrollment
500
Study start date
Sep 30, 2024
Study end date
Sep 30, 2026
Last updated
Mar 22, 2025
Primary purpose
N/A
Design
Observational
Intervention
Study phase
N/A
Allocation
N/A
Sponsor:
Power Life Sciences Inc.
Collaborator:
N/A
Investigator:
Michael B Gill
Publications
Websites
N/A
NCT06009549
| Clinic | Location | Investigator | Distance | RECRUITING STATUS | Contact |
|---|